Earnings Preview: Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is set to release its quarterly earnings results on Wednesday prior to the opening bell. Heading into the report, Wall Street analysts have consensus earnings estimates of $1.28 per share. The low estimate on the Street is $1.26 with a high estimate of $1.31. In the year ago period, Abbott reported EPS of $1.18.
Revenues are expected to be $9.93 billion which implies 1.20 percent sales growth versus last year's corresponding quarter. The low revenue estimate is $9.75 billion with a high estimate of $10.14 billion.
Over the last three months, EPS estimates for Abbot have risen by a penny. During this time, the stock has surged nearly 10 percent. Year-to-date, ABT has climbed almost 28 percent. On Tuesday, ahead of Wednesday's key report the stock was trading down 0.17 percent to $71.93 into the closing bell.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.